Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $4,652 - $4,875
70 Added 13.44%
591 $39,000
Q1 2024

Apr 15, 2024

SELL
$56.67 - $69.36 $8,613 - $10,542
-152 Reduced 22.59%
521 $35,000
Q4 2023

Jan 05, 2024

BUY
$49.38 - $63.75 $641 - $828
13 Added 1.97%
673 $41,000
Q3 2023

Oct 18, 2023

BUY
$48.64 - $62.51 $32,102 - $41,256
660 New
660 $37,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.